138 related articles for article (PubMed ID: 34228782)
1. Molecular mechanism of interspecies differences in the binding affinity of TD139 to Galectin-3.
Kumar A; Paul M; Panda M; Jayaram S; Kalidindi N; Sale H; Vetrichelvan M; Gupta A; Mathur A; Beno B; Regueiro-Ren A; Cheng D; Ramarao M; Ghosh K
Glycobiology; 2021 Nov; 31(10):1390-1400. PubMed ID: 34228782
[TBL] [Abstract][Full Text] [Related]
2. Efficient synthesis of a galectin inhibitor clinical candidate (TD139) using a Payne rearrangement/azidation reaction cascade.
St-Gelais J; Denavit V; Giguère D
Org Biomol Chem; 2020 May; 18(20):3903-3907. PubMed ID: 32400847
[TBL] [Abstract][Full Text] [Related]
3. Dissecting the Structure-Activity Relationship of Galectin-Ligand Interactions.
Chan YC; Lin HY; Tu Z; Kuo YH; Hsu SD; Lin CH
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29382172
[TBL] [Abstract][Full Text] [Related]
4. In silico-based Approach to Investigate the Ability of PEGylated Rapamycin to Inhibit Galectin-3.
Abdelkarim Maki MA; Kumar PV; Elumalai M; Bayazeid O
Curr Drug Discov Technol; 2021; 18(3):451-456. PubMed ID: 31969105
[TBL] [Abstract][Full Text] [Related]
5. Targeting the CRD F-face of Human Galectin-3 and Allosterically Modulating Glycan Binding by Angiostatic PTX008 and a Structurally Optimized Derivative.
Miller MC; Zheng Y; Suylen D; Ippel H; Cañada FJ; Berbís MA; Jiménez-Barbero J; Tai G; Gabius HJ; Mayo KH
ChemMedChem; 2021 Feb; 16(4):713-723. PubMed ID: 33156953
[TBL] [Abstract][Full Text] [Related]
6. Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N; MacKinnon AC; Nicol L; Ford P; Schambye H; Pedersen A; Nilsson UJ; Leffler H; Sethi T; Tantawi S; Gravelle L; Slack RJ; Mills R; Karmakar U; Humphries D; Zetterberg F; Keeling L; Paul L; Molyneaux PL; Li F; Funston W; Forrest IA; Simpson AJ; Gibbons MA; Maher TM
Eur Respir J; 2021 May; 57(5):. PubMed ID: 33214209
[TBL] [Abstract][Full Text] [Related]
7. Dual thio-digalactoside-binding modes of human galectins as the structural basis for the design of potent and selective inhibitors.
Hsieh TJ; Lin HY; Tu Z; Lin TC; Wu SC; Tseng YY; Liu FT; Hsu ST; Lin CH
Sci Rep; 2016 Jul; 6():29457. PubMed ID: 27416897
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 in Cardiovascular Diseases.
Blanda V; Bracale UM; Di Taranto MD; Fortunato G
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287402
[TBL] [Abstract][Full Text] [Related]
9. Resetting the ligand binding site of placental protein 13/galectin-13 recovers its ability to bind lactose.
Su J; Cui L; Si Y; Song C; Li Y; Yang T; Wang H; Mayo KH; Tai G; Zhou Y
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30413611
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Molecular Interactions of Symmetrical and Unsymmetrical Selenoglycosides with Human Galectin-1 and Galectin-3.
Pirone L; Nieto-Fabregat F; Di Gaetano S; Capasso D; Russo R; Traboni S; Molinaro A; Iadonisi A; Saviano M; Marchetti R; Silipo A; Pedone E
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955408
[TBL] [Abstract][Full Text] [Related]
11. Research progress on the role of gal-3 in cardio/cerebrovascular diseases.
Cao ZQ; Yu X; Leng P
Biomed Pharmacother; 2021 Jan; 133():111066. PubMed ID: 33378967
[TBL] [Abstract][Full Text] [Related]
12. Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells.
Cárcamo C; Pardo E; Oyanadel C; Bravo-Zehnder M; Bull P; Cáceres M; Martínez J; Massardo L; Jacobelli S; González A; Soza A
Exp Cell Res; 2006 Feb; 312(4):374-86. PubMed ID: 16368432
[TBL] [Abstract][Full Text] [Related]
13. Inhibition mechanism of human galectin-7 by a novel galactose-benzylphosphate inhibitor.
Masuyer G; Jabeen T; Öberg CT; Leffler H; Nilsson UJ; Acharya KR
FEBS J; 2012 Jan; 279(2):193-202. PubMed ID: 22059385
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship of Citrus segment membrane RG-I pectin against Galectin-3: The galactan is not the only important factor.
Wu D; Zheng J; Hu W; Zheng X; He Q; Linhardt RJ; Ye X; Chen S
Carbohydr Polym; 2020 Oct; 245():116526. PubMed ID: 32718630
[TBL] [Abstract][Full Text] [Related]
15. Structure-function studies of galectin-14, an important effector molecule in embryology.
Si Y; Li Y; Yang T; Li X; Ayala GJ; Mayo KH; Tai G; Su J; Zhou Y
FEBS J; 2021 Feb; 288(3):1041-1055. PubMed ID: 32525264
[TBL] [Abstract][Full Text] [Related]
16. Functional and structural bases of a cysteine-less mutant as a long-lasting substitute for galectin-1.
Nishi N; Abe A; Iwaki J; Yoshida H; Itoh A; Shoji H; Kamitori S; Hirabayashi J; Nakamura T
Glycobiology; 2008 Dec; 18(12):1065-73. PubMed ID: 18796645
[TBL] [Abstract][Full Text] [Related]
17. Evidence for subsites in the galectins involved in sugar binding at the nonreducing end of the central galactose of oligosaccharide ligands: sequence analysis, homology modeling and mutagenesis studies of hamster galectin-3.
Henrick K; Bawumia S; Barboni EA; Mehul B; Hughes RC
Glycobiology; 1998 Jan; 8(1):45-57. PubMed ID: 9451013
[TBL] [Abstract][Full Text] [Related]
18. Human galectin-1 and galectin-3 promote
Ayona D; Zarza SM; Landemarre L; Roubinet B; Decloquement P; Raoult D; Fournier PE; Desnues B
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 33573443
[No Abstract] [Full Text] [Related]
19. Full-length galectin-8 and separate carbohydrate recognition domains: the whole is greater than the sum of its parts?
Cagnoni AJ; Troncoso MF; Rabinovich GA; Mariño KV; Elola MT
Biochem Soc Trans; 2020 Jun; 48(3):1255-1268. PubMed ID: 32597487
[TBL] [Abstract][Full Text] [Related]
20. Revealing the Identity of Human Galectin-3 as a Glycosaminoglycan-Binding Protein.
Edwards JL; Kadav PD; Bandyopadhyay P; Dam TK
Methods Mol Biol; 2022; 2442():137-150. PubMed ID: 35320524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
